Cataldo Rita, Bruni Vincenzo, Migliorelli Sabrina, Gallo Ida Francesca, Spagnolo Giuseppe, Gibin Giulia, Borgetti Miriam, Strumia Alessandro, Ruggiero Alessandro, Pascarella Giuseppe
Unit of Anesthesia and Intensive Care, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
Research Unit of Anesthesia and Intensive Care, Department of Medicine and Surgery, Università Campus Bio-Medico, Rome, Italy.
Surg Endosc. 2025 Jun 30. doi: 10.1007/s00464-025-11870-7.
Patients undergoing laparoscopic gastric bypass (LGBP) commonly experience moderate to severe postoperative pain. We conducted a randomized, prospective double-blind placebo-controlled study to evaluate the analgesic effect of laparoscopic-guided TAP (LG-TAP) block after LGBP in a high-volume bariatric center, applying an enhanced recovery after metabolic and bariatric surgery protocol.
84 patients were randomly allocated to receive LG-TAP block with local anesthetic (LA) or saline solution (placebo), both combined with port-site infiltration with LA (LA-PSI). Primary outcome was pain score measured in post-anesthesia care unit (PACU), and at 6, 12, and 24 h after surgery. Secondary outcomes included postoperative nausea and/or vomiting, analgesic requirement, time to walking, time to flatus, length of hospital stay, and surgical complications.
Differences were observed in intra-group comparisons (LG-TAP vs. placebo) for the primary outcome-NRS in postoperative analgesia-with a median (IQR) NRS of 4 (2-5) vs. 2 (2-5) in PACU, 4.5 (2-6) vs. 2.5 (1-6) at 6 h and 3 (0-5) vs. 2 (0-4) at 12 h, although no statistically differences were demonstrated (PACU: p-value = 0.26; 6 h: p-value = 0.3; 12 h: p-value = 0.24). No statistically and clinically differences were observed for NRS at 24 h postoperatively with a median (IQR) of 1 (0-3) vs. 1 (0-4) at 24 h; p = 0.89. No differences were observed as regards secondary outcomes.
While a potential analgesic effect of saline solution through fascial hydrodissection cannot be excluded, our results more convincingly support that LG-TAP block provides no significant analgesic effect when LA-PSI is adequately implemented.
接受腹腔镜胃旁路手术(LGBP)的患者术后通常会经历中度至重度疼痛。我们在一家大型减肥中心进行了一项随机、前瞻性双盲安慰剂对照研究,采用代谢和减重手术后的强化康复方案,以评估LGBP术后腹腔镜引导下腹横肌平面(LG-TAP)阻滞的镇痛效果。
84例患者被随机分配接受局部麻醉药(LA)或生理盐水溶液(安慰剂)的LG-TAP阻滞,两者均联合LA进行切口周围浸润(LA-PSI)。主要结局指标为麻醉后恢复室(PACU)以及术后6、12和24小时的疼痛评分。次要结局指标包括术后恶心和/或呕吐、镇痛需求、行走时间、排气时间、住院时间以及手术并发症。
在主要结局指标——术后镇痛的数字疼痛评分量表(NRS)的组内比较(LG-TAP组与安慰剂组)中观察到差异,PACU中的NRS中位数(四分位间距)为4(2-5)比2(2-5),6小时时为4.5(2-6)比2.5(1-6),12小时时为3(0-5)比2(0-4),尽管未显示出统计学差异(PACU:p值=0.26;6小时:p值=0.3;12小时:p值=0.24)。术后24小时NRS的中位数(四分位间距)为1(0-3)比1(0-4),未观察到统计学和临床差异;p=0.89。在次要结局指标方面未观察到差异。
虽然不能排除生理盐水通过筋膜液压分离产生的潜在镇痛作用,但我们的结果更有力地支持了在充分实施LA-PSI时,LG-TAP阻滞没有显著的镇痛效果。